Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Accumulated Expenses (2016 - 2025)

CorMedix has reported Accumulated Expenses over the past 15 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $2.3 million for Q4 2025, down 92.7% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (down 92.7% YoY), and the annual figure for FY2025 was $2.3 million, down 92.7%.
  • Accumulated Expenses reached $2.3 million in Q4 2025 per CRMD's latest filing, down from $109.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $109.1 million in Q3 2025 and bottomed at $1.0 million in Q1 2021.
  • Median Accumulated Expenses over the past 5 years was $3.5 million (2024), compared with a mean of $11.1 million.
  • Peak annual rise in Accumulated Expenses hit 2178.19% in 2025, while the deepest fall reached 92.7% in 2025.
  • Over 5 years, Accumulated Expenses stood at $3.0 million in 2021, then soared by 31.84% to $4.0 million in 2022, then plummeted by 31.59% to $2.7 million in 2023, then soared by 1075.24% to $32.0 million in 2024, then tumbled by 92.7% to $2.3 million in 2025.
  • Business Quant data shows Accumulated Expenses for CRMD at $2.3 million in Q4 2025, $109.1 million in Q3 2025, and $3.6 million in Q2 2025.